HilleVax Statistics Share Statistics HilleVax has 50.14M
shares outstanding. The number of shares has increased by 0.72%
in one year.
Shares Outstanding 50.14M Shares Change (YoY) 0.72% Shares Change (QoQ) 0.67% Owned by Institutions (%) 84.35% Shares Floating 22.74M Failed to Deliver (FTD) Shares 9,863 FTD / Avg. Volume 2.11%
Short Selling Information The latest short interest is 458.69K, so 0.92% of the outstanding
shares have been sold short.
Short Interest 458.69K Short % of Shares Out 0.92% Short % of Float 2.17% Short Ratio (days to cover) 3.1
Valuation Ratios The PE ratio is -0.69 and the forward
PE ratio is -4.49.
HilleVax's PEG ratio is
0.53.
PE Ratio -0.69 Forward PE -4.49 PS Ratio 0 Forward PS 41.5 PB Ratio 0.66 P/FCF Ratio -0.93 PEG Ratio 0.53
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for HilleVax.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 10.84,
with a Debt / Equity ratio of 0.16.
Current Ratio 10.84 Quick Ratio 10.84 Debt / Equity 0.16 Debt / EBITDA -0.16 Debt / FCF -0.22 Interest Coverage 46.8
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-10.52M Employee Count 14 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 30.19% in the
last 52 weeks. The beta is 0.77, so HilleVax's
price volatility has been higher than the market average.
Beta 0.77 52-Week Price Change 30.19% 50-Day Moving Average 2.02 200-Day Moving Average 1.89 Relative Strength Index (RSI) 50.88 Average Volume (20 Days) 468,546
Income Statement
Revenue n/a Gross Profit n/a Operating Income -155.29M Net Income -147.27M EBITDA -155.29M EBIT -150.59M Earnings Per Share (EPS) -3
Full Income Statement Balance Sheet The company has 154.47M in cash and 24.51M in
debt, giving a net cash position of 129.95M.
Cash & Cash Equivalents 154.47M Total Debt 24.51M Net Cash 129.95M Retained Earnings -535.83M Total Assets 174.91M Working Capital 156.09M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -108.79M
and capital expenditures -522K, giving a free cash flow of -109.31M.
Operating Cash Flow -108.79M Capital Expenditures -522K Free Cash Flow -109.31M FCF Per Share -2.22
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
